Primary Insider Notification

15. Jun 2018 | 1 min read

Bård Sundrehagen, Chief Executive Officer in Gentian Diagnostics AS, has today sold 50,000 Shares in Gentian Diagnostics AS at a price of NOK 50 per share. Following the transaction, the total holding held by Bård Sundrehagen is 307,010 shares.

 

MeldingsID: 453767
UtstederID: GENT-ME
Instrument: GENT-ME
Marked: Merkur Market
Kategori: MELDEPLIKTIG HANDEL FOR PRIMÆRINNSIDERE
Informasjonspliktige opplysninger: Ja

Vedlegg: Primary insider notification Baard Sundrehagen (4)

You may also read


Apr 30, 2025 - Kristin Hart

Gentian Diagnostics: Invitation to presentation of first quarter results

Gentian Diagnostics ASA will present its first quarter 2025 results on 7 May 2025 at 10.00 CEST.

Apr 11, 2025 - Ole Sørlie

Gentian Diagnostics: Notice of annual general meeting

Gentian Diagnostics ASA’s annual general meeting will be held on Tuesday 6 May 2025 at 11:00 at the company’s..